|
KMID : 0360119930150010035
|
|
Journal of the Korean Society of Maxillofacial Plastic Reconstructive Surgeons
1993 Volume.15 No. 1 p.35 ~ p.48
|
|
|
Chemosensitivity of cancer cells to antioancer drugs using dye exclusion assay, [3H] thymidine incorporation, and clonogenic assay
|
|
|
|
|
Abstract
|
|
|
the in vitro predictive tests in cancer chamotherapy of cancer cell lines to anticancer drugs were determined using novel dye exclusion assay [NDEA], [3H] thymidine incorporation, and clonogenic assay [CA>. Antitumor effect of Bleomycin,
Cis-platin,
Vinblastine, Methotrexate to Hep-2, B16 cell lines using rapid assays was compared with [CA> in this study.
In dye exclusion assay of B 16 cell line, cancer cells were sensitive to Bleomycin at all concentrations, to Vinblastine at the level of peak plasma concentration [PPC], ×1/10 [PPC](P<0.05). and bleomycin revealed relatively good cytotoxicity
than
that
of CDDP and vinblastine at ×10 [PPC], (P<0.05).
Hep-2 cell swere resistive to methotrexate at the level of ×100 [PPC] (P<0.05)
In [3H] thymidine incorporation assay, B 16 cells were sensitive to Bleomycin, CDDP, Vinblastine at the level of [PPC], ×10 [PPC] (P<0.01).
Dose-dependent drugs of bleomycin, CDDP were more sensitive than Vinblastine at high concentration (P<0.05).
In clonogenic assay, Hep-2 cell line was sensitive to three drugs of all concentrations except ×1/10 [PPC] of CDDP. B 16 cell line was sensitive to all drugs (P<0.01).
In comparison of chemosensitivity tests among three assays, the results were correlated (γ=0.99, P<0.05).
|
|
|
KEYWORD
|
|
|
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
 
|
|